Archived Newsletters

  1. 11.22.17 -- Bigger Pharma Supports Biotech Outsourcing
    11/22/2017
    11/22/17 Outsourced Pharma Newsletter
  2. 11.16.17 -- Innovative Approaches For Enhancing Bioavailability
    11/16/2017
    11/16/17 Outsourced Pharma Newsletter
  3. 11.15.17 -- You Can Do Everything Right, But Still Get Burned By Outsourcing
    11/15/2017
    11/15/17 Outsourced Pharma Newsletter
  4. 11.09.17 -- Challenges In API Development, Formulation, And Scale-Up
    11/9/2017
    11/09/17 Outsourced Pharma Newsletter
  5. 11.08.17 -- Lessons From Mersana's Outsourced Model For ADCs
    11/8/2017
    11/08/17 Outsourced Pharma Newsletter
  6. 11.01.17 -- Outsourcing Dreams In Latin America
    11/1/2017
    11/01/17 Outsourced Pharma Newsletter
  7. 10.31.17 -- Monoclonal Antibodies: Novel Analytical Techniques, Optimizing Titer, Flexible Manufacturing
    10/31/2017
    10/31/17 Outsourced Pharma Newsletter
  8. 10.25.17 -- Boehringer Ingelheim And The Two Sides Of Biologics Outsourcing
    10/25/2017
    10/25/17 Outsourced Pharma Newsletter
  9. 10.24.17 -- Assessing The Economics Of Single-Source Vs. Multi-Vendor Manufacturing
    10/24/2017
    10/24/17 Outsourced Pharma Newsletter
  10. 10.18.17 -- Two Strategies For Getting Your CMO To Really Listen
    10/18/2017
    10/18/17 Outsourced Pharma Newsletter